Director, Center for Biodesign
Frederic Zenhausern, PhD, focuses on merging new technology with genomics and molecular biology to develop ways to diagnose disease, monitor health and create flexible electronics. Zenhausern is excited by the freedom of thinking, state-of-the-art infrastructure, great leadership and stimulating intellectual environment offered by the Biodesign Institute.
In addition to his Biodesign and academic roles, he is co-founder of the newly formed Flexible Displays Center at Arizona State University; a $100 million ASU-led national research facility between the U.S. Army, five universities and more than 20 industrial partners.
Early in his career, Zenhausern was a research scientist at IBM’s Watson Research Center where he co-developed the apertureless near-field optical system for applications ranging from DNA sequencing to high density mass data storage. Since leaving IBM, Zenhausern has had several research positions at Firmenich Inc., Alpha-MOS America and, more recently, Motorola Labs in Arizona, where he was manager of the microdevice physics labs in Arizona.
He has co-authored more than 35 scientific publications and filed 13 U.S. patents comprising several publications and pending disclosures in sensor monitoring technology. His curiosity drives his passion to develop a technology that will one day be used by a clinician to benefit a patient. To achieve this end, Zenhausern has co-founded NanoBiomics Inc. to develop and commercialize a novel diagnostic platform for human disease.
Zenhausern received his BS in biochemistry and his PhD in applied physics from the University of Geneva. He also has an MBA in finance from Rutgers University.
Speaking in the symposiums on Micro & Nano Fluidics